Tag: GSK

Sanofi-GSK’s Covid vaccine, effective against omicron, could hit the market this year

Global Markets Pharma - 24.06.2022

Sanofi and GSK today announce positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta...

GSK shares lost 3.85% in the last month

Global Markets Pharma - 17.06.2022

In the latest trading session, GlaxoSmithKline (GSK) closed at $41.64, marking a -0.74% move from the previous day. This...

GSK comes close to creating a hard-to-reach RSV vaccine

Drug Development Pharma - 11.06.2022

GSK aims to get its respiratory syncytial virus (RSV) vaccine to regulators for review later this year, after interim...

Pfizer sells its stake in Haleon, GSK’s consumer healthcare division

Global Markets Pharma - 02.06.2022

Pfizer will sell down its stake in Haleon, the consumer healthcare unit of GSK, after its listing in London...

GSK buys Affinivax for up to $3.3 billion

Global Markets Pharma - 01.06.2022

GSK plc announced that it has entered into a definitive agreement to acquire Affinivax, Inc. (Affinivax), a clinical-stage biopharmaceutical...

SK bioscience has reached the final stage of development of Korea’s first COVID-19 vaccine

Drug Development Pharma - 03.05.2022

SK bioscienceSK bioscience and GSK announced submission of a biologics license application for SKYCovione™ a recombinant protein-based COVID-19 vaccine...

GSK shows strong sales performance in the first quarter of 2022 – £9.8 billion

EAEU Market Pharma - 28.04.2022

British pharmaceutical giant GSK (GSK.L) on Wednesday beat analysts' expectations for its first-quarter results and reaffirmed its 2022 forecast. Highlights Strong...

GSK expands oncology product line by acquiring Sierra Oncology for $1.9 billion

Global Markets Pharma - 14.04.2022

GlaxoSmithKline plc and Sierra Oncology, Inc April 13th announced that the companies have entered into an agreement under which...

CureVac and GSK contract with German government enabling rapid availability of 80 million mRNA-based vaccine

Global Markets Pharma - 11.04.2022

CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”),...

LifeMine and GSK sign cooperation agreement to search for small molecules

Global Markets Pharma - 24.03.2022

LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere, today...

GSK halts phase III vaccine trial of respiratory virus in pregnant women

Global Markets Pharma - 28.02.2022

GlaxoSmithKline, a science-led global healthcare company, on Monday announced that the Company has decided to stop enrolment and vaccination...

FDA limits use of GlaxoSmithKline and Vir’s COVID-19 antibody treatment in some geographic areas

Global Markets Pharma - 25.02.2022

The United States Food and Drug Administration stated GlaxoSmithKline and Vir Biotech's COVID-19 antibody treatment should not be...

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Hot topics

Manufacturing

Global Markets

Politics

AI in Pharma

Hot topics

Manufacturing

Global Markets

Politics

AI in Pharma

Tag: GSK

Company

Headlines

Newsletter